Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Malcolm S. Taub currently holds 77,332 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Malcolm S. Taub has been a net seller of BCLI stock. They have purchased $0 and sold $542.4K worth of shares.
Malcolm S. Taub's most recent insider trade was on Dec 15, 2021, when they sold 12,000 shares at $0.00 per share.
Malcolm S. Taub serves as Executive at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have executed 35 insider transactions totaling $542.4K over their tenure at the company.
Malcolm S. Taub holds the position of Executive at BRAINSTORM CELL THERAPEUTICS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Malcolm S. Taub has shown a selling trading pattern, with $0 in total purchases and $542.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Malcolm S. Taub was on Sep 14, 2009, when they sold $87.5K worth of BCLI shares. This transaction involved 350,000 shares at $0.25 per share.
Malcolm S. Taub currently owns 77,332 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Malcolm S. Taub's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Malcolm S. Taub has 35 Form 4 filings on record as an insider at BRAINSTORM CELL THERAPEUTICS INC..
Set alerts for Malcolm S. Taub and 40,000+ other insiders.